Cuba, China to Jointly Produce Larvicide (China)
This article was originally published in PharmAsia News
Cuba and China have signed an agreement for China to finance a production project in Cuba to produce large-scale quantities of a larvicide called Bactivec. This larvicide helps combat dengue fever outbreaks, and Cuba has been looking to boost its own domestic production of Bactivec. China also will sell Cuba 6 million doses of Bactivec under the deal, and donate 500,000. Dengue fever is spread through the Aedes Aegypti mosquito, and up to 20 percent of patients may die from it. (Click here for more
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.